delta opioid receptor in neuronal cells undergoes acute and homologous desensitization

被引:38
作者
Cai, YC [1 ]
Zhang, Y [1 ]
Wu, YL [1 ]
Pei, G [1 ]
机构
[1] CHINESE ACAD SCI,SHANGHAI INST CELL BIOL,SHANGHAI 200031,PEOPLES R CHINA
关键词
D O I
10.1006/bbrc.1996.0235
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Using delta opioid receptor as a model system, acute desensitization of neuronal opioid receptor was studied in detail in neuroblastoma x glioma NG108-15 cells and primarily-cultured mouse cortical cells. The opioid desensitization could occur in as short as 3 minutes oi agonist treatment and the half-life of the desensitized stare was about 90 minutes. This acute opioid desensitization was homologous in nature in both neuronal cells. The acute desensitization was almost abolished by treatment of the neuronal cells. The acute desensitization was almost abolished by treatment of the neuronal cells with staurosporine. a nonspecific protein kinase inhibitor. Treatment with the protein kinase C-selective inhibitor, calphostin C, however, caused partial block. In conclusion, neuronal opioid receptor undergoes acute, agonist-dependent, and homologous desensitization, during which protein kinases appear to play an important role. (C) 1996 Academic Press, Inc.
引用
收藏
页码:342 / 347
页数:6
相关论文
共 20 条
[1]  
Aghajanian G. K., 1992, Society for Neuroscience Abstracts, V18, P21
[2]  
BERGSBAKEN CL, 1993, J PHARMACOL EXP THER, V264, P1474
[3]  
CHEN Y, 1994, J BIOL CHEM, V269, P7839
[4]   SPECIES AND AGE-DEPENDENT DIFFERENCES OF FUNCTIONAL COUPLING BETWEEN OPIOID DELTA-RECEPTOR AND G-PROTEINS AND POSSIBLE INVOLVEMENT OF PROTEIN-KINASE-C IN STRIATAL MEMBRANES [J].
FUKUSHIMA, N ;
UEDA, H ;
HAYASHI, C ;
KATAYAMA, T ;
MIYAMAE, T ;
MISU, Y .
NEUROSCIENCE LETTERS, 1994, 176 (01) :55-58
[5]   PHOSPHORYLATED MU-OPIOID RECEPTOR PURIFIED FROM RAT BRAINS LACKS FUNCTIONAL COUPLING WITH GI1, A GTP-BINDING PROTEIN IN RECONSTITUTED LIPID VESICLES [J].
HARADA, H ;
UEDA, H ;
KATADA, T ;
UI, M ;
SATOH, M .
NEUROSCIENCE LETTERS, 1990, 113 (01) :47-49
[6]  
HARRIS GC, 1991, J NEUROSCI, V11, P2574
[7]  
LAW PY, 1983, MOL PHARMACOL, V23, P26
[8]  
LAW PY, 1982, MOL PHARMACOL, V22, P1
[9]  
LAW PY, 1984, J BIOL CHEM, V259, P4096
[10]  
LAW PY, 1983, MOL PHARMACOL, V24, P413